首页> 外文期刊>The British Journal of Nutrition >Starch-entrapped microspheres show a beneficial fermentation profile and decrease in potentially harmful bacteria during in vitro fermentation in faecal microbiota obtained from patients with inflammatory bowel disease
【24h】

Starch-entrapped microspheres show a beneficial fermentation profile and decrease in potentially harmful bacteria during in vitro fermentation in faecal microbiota obtained from patients with inflammatory bowel disease

机译:淀粉包裹的微球在体外发酵过程中表现出有益的发酵特性,并减少了从炎症性肠病患者获得的粪便微生物群中潜在有害细菌的数量

获取原文
获取原文并翻译 | 示例
           

摘要

The purpose of this research was to test the hypothesis that starch-entrapped microspheres would produce favourable fermentation profiles and microbial shifts during in vitro fermentation with the faecal microbiota from patients with inflammatory bowel disease (IBD). In vitro fermentation was carried out using a validated, dynamic, computer-controlled model of the human colon (Toegepast Natuurwetenschappelijk Onderzoek gastro-intestinal model-2) after inoculation with pooled faeces from healthy individuals, patients with inactive IBD (Crohn's disease (CD)) or patients with active IBD (ulcerative colitis (UC)). Starch-entrapped microspheres fermented more slowly and produced more butyrate than fructo-oligosaccharides (FOS) when fermented with the faecal microbiota from patients with active UC. When fermented with the microbiota from patients with inactive CD, starch-entrapped microspheres also fermented more slowly but produced similar amounts of butyrate compared with FOS. Starch-entrapped microspheres showed a greater ability to maintain a low pH during simulated-distal colon conditions compared with FOS. After fermentation with the microbiota from inactive CD patients, starch-entrapped microspheres resulted in lower concentrations of some potentially harmful gut bacteria, included in Bacteroides, Enterococcus, Fusobacterium and Veillonella, compared with FOS. These findings suggest that slow fermenting starch-entrapped microspheres may induce a favourable colonic environment in patients with IBD through high butyrate production, maintenance of low pH in the distal colon and inhibition of the growth of potentially harmful bacteria.
机译:这项研究的目的是检验以下假设:在患有炎症性肠病(IBD)的患者的粪便菌群的体外发酵过程中,淀粉糊化微球会产生有利的发酵特性和微生物迁移。接种来自健康个体,无活性IBD(克罗恩病(CD))患者的粪便后,使用经过验证的动态计算机控制人结肠模型(Toegepast Natuurwetenschappelijk Onderzoek胃肠道模型2)进行体外发酵)或活动性IBD(溃疡性结肠炎(UC))患者。与果糖寡糖(FOS)相比,包裹有淀粉的微球与活动性UC患者的粪便菌群发酵时,发酵速度更慢,丁酸生成率更高。当用无活性CD患者的微生物群发酵时,与FOS相比,包裹淀粉的微球发酵速度也较慢,但产生的丁酸盐量相似。与FOS相比,包裹淀粉的微球在模拟远距离结肠条件下表现出更大的保持低pH的能力。与来自FOS的微生物相比,在非活动性CD患者的细菌群落中发酵后,包裹淀粉的微球导致细菌,肠球菌,梭菌和Veillonella中包括的某些潜在有害肠道细菌的浓度降低。这些发现表明,通过高丁酸生成,维持远端结肠低pH值和抑制潜在有害细菌的生长,缓慢发酵的淀粉包裹微球可能会为IBD患者带来良好的结肠环境。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号